IMS Health Holdings (NYSE:IMS) has tumbled 3.33% during the past week and has dropped 3.33% in the last 4 week period. The stocks are negative as compared to the S&P 500 for the past week with a loss of 2.17%. IMS Health Holdings (NYSE:IMS) has underperformed the index by 4.22% in the last 4 weeks. Investors should watch out for further signals and trade with caution.
IMS Health Holdings (NYSE:IMS): The stock opened at $25.00 on Friday but the bulls could not build on the opening and the stock topped out at $25.21 for the day. The stock traded down to $24.65 during the day, due to lack of any buying support eventually closed down at $24.65 with a loss of -1.48% for the day. The stock had closed at $25.02 on the previous day. The total traded volume was 2,114,435 shares.
The company shares have dropped -22.63% from its 1 Year high price. On Jul 31, 2015, the shares registered one year high at $33.52 and the one year low was seen on Jan 28, 2016. The 50-Day Moving Average price is $25.41 and the 200 Day Moving Average price is recorded at $25.40.
On the companys insider trading activities, The officer (SVP, Information Offerings), of Ims Health Holdings, Inc., Knightly Kevin C had unloaded 19,231 shares at $28.5 per share in a transaction on November 23, 2015. The total value of transaction was $548,084. The Insider information was revealed by the Securities and Exchange Commission in a Form 4 filing.
Many analysts have stated their opinion on the company shares. Equity Analysts at the Wells Fargo downgrades the rating on IMS Health Holdings (NYSE:IMS). The brokerage firm has issued a Market Perform rating on the shares. The shares were previously rated Outperform. The rating by the firm was issued on May 12, 2016. Currently the company Insiders own 2.5% of IMS Health Holdings shares according to the proxy statements. Institutional Investors own 90.99% of IMS Health Holdings shares.
IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Companys data set contains over 10 petabytes of data and over 500 million patient records. The Company serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Companys principal offerings include national information offerings, sub-national information offerings, workflow analytics, real-world evidence (RWE) solutions, technology and applications and clinical solutions.